← 홈

HER2+ 유방암

465개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 465개
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 1

trastuzumab (Herceptin, SYD985, Vic-trastuzumab duocarmazine, Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

HER2-positive Breast Cancer; HER2 Low · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 27.8%임상시험 7상태 DISCONTINUED
ADCBiologicstaleHoffmann-La RochePhase 2

Atirmociclib (Atirmociclib)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
ADCBiologicstaleSenhwa Biosciences, Inc.Phase 1

Pidnarulex (Pidnarulex)

Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8 · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
ADCBiologicstaleAstraZenecaPreclinical

TDxd (TDxd)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
ADCBiologicstaleSichuan Kelun-Biotech Biopharma…Phase 3

A166 (A166)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
ADCBiologicstaleDualityBio Inc.Phase 3

DB-1303/BNT323 (DB-1303/BNT323)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
ADCBiologicstaleRayzeBio, Inc.Phase 2

RYZ101 (RYZ101)

Metastatic Breast Cancer; HER2-negative Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 5상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

SGN-LIV1A (SGN-LIV1A)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 34%임상시험 5상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Talazoparib plus Irinotecan (Talazoparib plus Irinotecan)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 0.0%임상시험 5상태 RECRUITING
ADCBiologicstaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab emtansine [Kadcyla])

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 9.7%임상시험 5상태 ACTIVE
ADCBiologicstaleHoffmann-La RochePhase 2

ZN-A-1041 (ZN-A-1041)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 5상태 RECRUITING
ADCBiologicstaleArtiva Biotherapeutics, Inc.Phase 2

AB-201 (AB-201)

Breast Cancer; Gastric Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 DISCONTINUED
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Amcenestrant + Letrozole (Amcenestrant + Letrozole)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 42.3%임상시험 4상태 RECRUITING
ADCBiologicstaleRochePhase 2

trastuzumab (Herceptin, Patritumab and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 4상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, SD-101 + Pembrolizumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 3.2%임상시험 4상태 RECRUITING
AntibodystaleRegeneronPhase 2

VV1 + Cemiplimab (VV1 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 4상태 RECRUITING
ADCBiologicQuantumLeap Healthcare Collabor…Phase 2

ARV-471 + Letrozole (ARV-471 + Letrozole)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 3상태 RECRUITING
ADCBiologicAstraZenecaPLPhase 2

AZD8205 (AZD8205)

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 3상태 RECRUITING
ADCBiologicstaleBioAtla, Inc.Phase 2

CAB-ROR2-ADC (CAB-ROR2-ADC)

Non Small Cell Lung Cancer; Triple Negative Breast Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 ACTIVE
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin+Anlotinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 ACTIVE

10 / 24 페이지

← 이전다음 →